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ENGLISH SUMMARY 
Atrial fibrillation (AF) is a common cardiac arrhythmia and the 
prevalence increases with age. AF can cause embolization of thrombi 
from the atria’s to the brain and account for no less than 20% of strokes. 
The prevalence is increasing, thus, AF is a growing epidemic and a 
serious public health concern and there is a need for preventive 
initiatives. Previous studies have suggested that saturated fatty acids 
(SFA) may be associated with incident AF.  
This thesis and related papers were based on the Danish cohort “Diet, 
Cancer and Health” including dietary information and adipose tissue 
biopsies from more than 57.000 participants. The a priori hypothesis was 
that SFA were associated with a higher incidence of AF and three studies 
were designed to explore this hypothesis. 
First, we investigated if replacing dietary SFA with monounsaturated 
fatty acids (MUFA) or polyunsaturated fatty acids (PUFA) was 
associated with a lower risk of AF using substitution models. Analyses 
found a statistically significant direct association for developing AF in 
men when replacing dietary SFA with total n-3 PUFA. In women and 
when substituting SFA with MUFA and other PUFA, we found a neutral 
association with AF. 
Subsequently, we examined the association between adipose tissue 
content of SFA and the risk of developing AF in a case-cohort study with 
Cox proportional hazard regression. We found a neutral association 
between adipose tissue content of SFA and the risk of incident AF in both 
men and women. 
 
Lastly, the third study explored the association between adipose tissue 
patterns of fatty acid identified by the statistical method treelet 
transform and the risk of developing AF. We found that an adipose tissue 
fatty acid pattern with SFA was associated with a statistically significant 
lower hazard of AF in women but not in men. In both men and women 
patterns with n-6 PUFA may be associated with a lower hazard of AF, 
while patterns with marine n-3 PUFA and n-9 fatty acids were 
associated with a lower hazard of AF in women.
VII
DANSK RESUME 
Atrieflimren (AF) er en hyppigt forekommende hjerterytmeforstyrrelse 
og hyppigheden stiger med alderen. AF kan forårsage dannelse af 
tromber i atrierne med efterfølgende risiko for embolisering til hjernen. 
AF er skyld i mere end 20% af apopleksi tilfælde. Grundet en stigende 
prævalens er der behov for nye profylaktiske tiltag. Tidligere studier har 
antydet en association mellem mættet fedt og udviklingen af AF. 
Denne afhandling, og studierne den er baseret på, bygger på den danske 
kohorte ”Kost, kræft og helbred”. Kohorten indeholder information om 
kost og fedtvævsbiopsier fra mere end 57.000 deltagere. 
Arbejdshypotesen var, at mættet fedt er associeret med en øget risiko for 
udvikling af AF, og tre studier blev designet for at afsøge denne 
hypotese. 
Det første studie undersøgte med Cox regression, hvordan substitution af 
mættet fedt i kosten med mono- og polyumættede fedtsyrer påvirkede 
associationen med AF. Vi fandt, at hvis mænd erstattede mættet fedt 
med omega-3 polyumættet fedt, var der en øget risiko for AF. Hos 
kvinder og ved substitution med andre mono- og polyumættede fedtsyrer 
var associationen neutral. 
Det andet studie omhandlede associationen mellem fedtvævs indhold af 
mættet fedt og risikoen for AF i et case-kohorte studie med Cox 
regression. Vi fandt, at indholdet af mættet fedt i fedtvæv var neutralt 
associeret med risikoen for at udvikle AF hos både mænd og kvinder. 
Det sidste studie undersøgte associationen mellem fedtvævs 
fedtsyremønstre identificeret med treelet transform og risikoen for at 
udvikle AF. Studiet viste, at hos kvinder var mønstre med mættet fedt, 
marine omega-3 polyumættede fedtsyrer og omega-9 fedtsyrer 
associerede med en lavere risiko for AF. Ved begge køn var der en mulig 
association mellem omega-6 polyumættede fedtsyrer og en lavere risiko 
for AF.  
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 INTRODUCTION 
Atrial fibrillation (AF) is a common cardiac arrhythmia affecting 1-2% of 
the population. The prevalence increases with age reaching 5-15% at an 
age of >80 years (1). In 2010, the worldwide number of AF patients was 
believed to be 33.5 million (2). This number is estimated to rise 
substantially in the future due in part to the aging population and an 
increase in established risk factors for AF such as diabetes mellitus and 
obesity, as well as better treatment and survival of cardiovascular 
diseases with a predisposition for AF (1,3–5). AF is associated with 
higher mortality and morbidity (6,7) including a five-fold higher risk of 
stroke and a three-fold higher incidence of heart failure (8). Thus, AF is 
to be considered a growing epidemic and a serious public health concern 
(6) with an urgent need for preventive initiatives.  
The association between dietary components and AF has been 
investigated previously. Thus, heavy alcohol drinking has been found to 
be associated with an higher risk of AF while a moderate alcohol intake 
does not affect the risk (9,10). Regarding fatty acids, some studies have 
explored the association between marine n-3 polyunsaturated fatty acids 
(PUFA) or fish intake and the risk of AF and reported inconsistent 
results (11–16). Finally, two previous studies have suggested that 
saturated fatty acids (SFA) may be related to the development of AF 
(17,18) with diverging results. 
This thesis explores the association between SFA in the diet and in 
adipose tissue and the risk of developing AF, and how adipose tissue 
patterns of fatty acids is associated with the risk of incident AF.
CHAPTER 2. BACKGROUND 
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 BACKGROUND 
2.1. ATRIAL FIBRILLATION 
In patients with AF, the electric activity of the atria is irregular, which 
leads to a disturbed coordination of impulses from the atria to the 
ventricles. This, in turn, leads to an irregular and often rapid heart 
rhythm. 
The electrocardiogram defining AF has three characteristics (1,7): 
1. The RR intervals are absolutely irregular.
2. There are no distinct P waves.
3. The interval between atrial activation (if visible) is usually variable
and >300 beats per minute.
An example of a section of an electrocardiogram from a patient with AF 
is shown in Figure 1. 
Figure 1. A section of an electrocardiogram showing 
characteristic AF. 
AF is divided in to four types according to the duration and clinical 
presentation of the arrhythmia (1):  
1. Paroxysmal AF: Self-terminating within 7 days.
2. Persistent AF: If the AF episode lasts more than 7 days or requires
termination by cardioversion.
3. Long-standing persistent AF: AF lasting for more than one year and a
rhythm control strategy has been chosen.
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4. Permanent AF: The arrhythmia is accepted by the patient and 
further attempts to achieve rhythm control is not pursued.  
 
AF is a progressive disease and the pathophysiology contains at least 
three components: initiation, maintenance and progression to longer-
lasting forms of AF. Each episode of AF is initiated by a trigger acting on 
a vulnerable substrate. Ectopic firing is often located in the pulmonary 
veins and can initiate a re-entry arrhythmia in a susceptible substrate 
caused by electrical or structural remodeling of the atria, which in turn 
can maintain the arrhythmia (19,20). Atrial fibrosis affects atrial 
electrophysiology and can cause ectopic firing and conduction-slowing 
(21) favouring re-entry arrhythmias where the atria has to have regained 
excitability. The last-mentioned is also favoured by atrial enlargement 
(22). AF itself can cause remodeling of the atria, both structural and 
electrical, which makes the atria more vulnerable, thus reinforcing the 
arrhythmia (19,22,23).  
Progression is caused by remodeling due to the arrhythmia and due to 
aging and other heart diseases e.g. hypertension or heart failure (20). 
 
The patients may experience symptoms such as palpitations, dyspnoea 
and fatigue, often leading to a lower quality of life (24). Furthermore, AF 
can facilitate the formation of thrombi in the atria which can cause 
embolization to the brain giving rise to an ischemic stroke. AF accounts 
for no less than 20% of all strokes and the sequelae after a stroke tend to 
be more severe in patients with AF (25,26). Depending on patients’ risk 
profile for stroke, patients may require lifelong anticoagulant treatment 
in the form of vitamin K antagonist or non-vitamin K antagonist oral 
anticoagulants, which may have serious adverse effects such as bleeding 
episodes (1). Also, untreated AF is associated with an increased risk of 
heart failure (27).  
 
Risk factors for developing AF include male sex (7), hypertension (7,28), 
age (29), smoking (30), obesity (7,31,32), previous myocardial infarction 
(3), diabetes mellitus (33–35), heart failure (3,6,7), chronic kidney disease 
(6,36) and heredity (6,7,20). 
 
AF is closely related to the less common arrhythmia atrial flutter (AFL), 
which is a more organized re-entry tachycardia with regular rapid 
activation of the atria. Symptoms and complications are similar to AF 
and the conditions often coexist. 
  
CHAPTER 2. BACKGROUND 
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2.2. FATTY ACIDS 
Fatty acids are classified according to the number and location of double 
bonds in the carbon chain. SFA have no double bonds. Monounsaturated 
fatty acids (MUFA) have one double bond and PUFA have two or more 
double bonds in the carbon chain (Figure 2). The MUFA and PUFA are in 
addition named e.g. n-3, n-6 or n-9 referring to whether the first double 
bond is placed at carbon atom number 3, 6 or 9 counted from the methyl 
end of the chain. Thus, a specific fatty acid, e.g linoleic acid is 
characterized as shown in Figure 2, where C:18:2, n-6 refers to a fatty 
acid with 18 carbon atoms and two double bonds, where the first is 
placed at carbon atom number 6. Cis and trans are terms that refer to 
the configuration around the double bond. Most naturally occurring fatty 
acids are in the cis configuration, while trans fatty acids are derived from 
meat and dairy products from ruminants, where the fatty acids are 
produced by the action of bacteria in the ruminant stomach (37), or are 
products of industrial processing. 
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Figure 2. The classification of fatty acids. Reproduced with 
permission from A. Gammelmark, Dissertation 2016: Marine n-3 Fatty 
Acids and Genetic Variants in the 5-Lipoxygenase Pathway. Copyright: 
Anders Gammelmark. 
The body’s endogenous exposure to SFA is determined by the dietary 
intake and de novo lipogenesis from ingested carbohydrates and proteins 
(38–42). Dietary sources for the main SFA are shown in Table 1. 
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Composition Name Dietary Sources (18,43,44) 
C12:0 Lauric acid Dairy products, palm oil, sunflower 
oil  
C14:0 Myristic acid Dairy products, sunflower oil 
C16:0 Palmitic acid Meat, dairy products and palm oil 
C18:0 Stearic acid Bovine meat, dairy products and 
palm oil 
C20:0 Arachidic acid Peanuts and canola oil 
C22:0 Behenic acid Peanuts and canola oil 
C24:0 Lignoceric acid Peanuts and canola oil 
Table 1. Number of carbon atoms, name and main dietary 
sources of saturated fatty acids.  
In the de novo lipogenesis pathway fatty acids are formed when acetyl-
coenzyme A are polymerized. The major product of this polymerization is 
C16:0 (palmitic acid), whereas C14:0 (myristic acid) is a minor product of 
the synthesis. Furthermore, C16:0 can be processed by elongation and/or 
desaturation to other fatty acids e.g. the MUFA C18:1 n-9 (oleic acid) 
(41). 
2.3. SATURATED FATTY ACIDS AND ATRIAL FIBRILLATION 
Recently, Fretts et al. (18) investigated the association between plasma 
phospholipid SFA and the risk of developing AF in American adults (both 
Caucasians and Blacks). The participants were ≥65 years of age without 
cardiovascular disease at baseline and participated in the Cardiovascular 
Health Study. Plasma levels of C16:0 to 24:0 were expressed as weight 
percentage of total phospholipid fatty acids analysed, while information 
on AF was based on annual electrocardiograms or hospital discharge 
diagnoses. The cohort for this analysis consisted of 2,899 participants of 
whom 707 developed AF during a median follow-up of 11.2 years. The 
authors concluded that higher circulating plasma levels of C16:0 were 
associated with a higher risk of AF when comparing the highest with the 
lowest quartile with a HR of 1.48 (95% CI 1.18 to 1.86) in the 
multivariate model and the trend was statistically significant. In 
contrast, circulating levels of C18:0 to 24:0 were associated with a lower 
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risk of incident AF (p-value ≤0.01) when comparing the second to the 
fourth quartiles with the first quartile. When investigating combined 
circulating levels of C16:0 to C24:0 there was, however, no statistically 
significant association with the risk of developing AF. 
The association between SFA in the diet and AF has been investigated in 
the Women’s Health Study, which was established to investigate the 
effect of low-dose aspirin, β-carotene, and vitamin E in the primary 
prevention of cardiovascular disease (CVD) and cancer in American, 
female health care professionals (17). Dietary data from a baseline food-
frequency questionnaire (FFQ) were used to investigate the risk of AF 
when energy from dietary carbohydrates was replaced by energy from 
MUFA or SFA. The participating 33,665 women were ≥45 years of age 
and free of CVD at baseline. Information on AF was obtained from 
questionnaires answered by participants and from medical records. The 
study included 1,441 cases of AF during a median of 19.2 years of follow-
up. The authors found that a 5% higher intake of energy from SFA 
replacing carbohydrates was associated with a higher risk of persistent 
and chronic AF with a HR of 1.47 (95% CI 1.04 to 2.09) in a multivariate 
analysis. The risk of developing paroxysmal AF was not statistically 
significant with a HR of 0.85 (95% CI 0.66 to 1.08). The p-value for the 
difference between developing paroxysmal or persistent/chronic AF was 
0.01. If energy from MUFA replaced carbohydrates, there was a 
statistically significant lower risk of persistent and chronic AF with a HR 
of 0.67 (95% CI 0.46 to 0.98), while the HR for development of 
paroxysmal AF was 1.03 (95% CI 0.78 to 1.34) in the multivariate model. 
The p-value for the difference between developing paroxysmal and 
persistent/chronic AF was 0.07. Thus, the authors suggested that dietary 
fatty acids might prevent AF progression rather than preventing the 
initiation of the arrhythmia. The study also investigated the association 
between quintiles of SFA intake in energy percentages and the risk of 
incident AF with the first quintile as the reference. The authors did not 
find a statistically significant association between dietary intake of SFA 
and the risk of paroxysmal AF. However, there was a statistically 
significant positive association between SFA intake and 
persistent/chronic AF comparing the fifth quintile and the first quintile. 
This model does not account for substitution aspects. In substitution a 
dietary component is replaced by another, while keeping energy intake 
constant e.g. having a higher intake of SFA and a concomitantly lower 
intake of carbohydrates. 
The mechanism(s) by which SFA may affect the risk of incident AF is not 
fully established. However, it has been suggested that C16:0 ceramide 
accumulation in cells may increase the permeability of the mitochondrial 
CHAPTER 2. BACKGROUND 
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membrane to proteins, leading to apoptosis (45). Subsequently, apoptosis 
may impair intermyocyte coupling due to the formation of fibrosis, which 
has been shown to cause a substrate for AF initiation in dogs (19,46,47). 
Also in dogs, Soloff (48) have shown that rapid infusion of C16:0 and 
C18:0 may cause arrhythmias - primarily conduction defects, while slow 
infusion of C16:0 and C18:0 and rapid infusion of MUFA and PUFA did 
not provoke arrhythmias. 
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 AIMS AND HYPOTHESES 
The overall aim of this thesis was to evaluate the potential association 
between SFA and the risk of developing AF. The a priori hypothesis was 
that SFA were associated with a higher incidence of AF. The following 
three studies were designed to explore this hypothesis. 
 
Study 1 
Aim: To investigate how dietary substitution of SFA with MUFA or 
PUFA is associated with the risk of incident AF. 
Hypothesis: Replacing dietary SFA with unsaturated fatty acids reduce 
the risk of AF. 
 
Study 2 
Aim: To examine the association between adipose tissue content of SFA 
and the risk of AF. 
Hypothesis: Adipose tissue content of SFA are associated with a higher 
risk of AF. 
 
Study 3 
Aim: To explore the association between adipose tissue patterns of fatty 
acids and the risk of developing AF. 
Hypothesis: Various patterns of fatty acids in adipose tissue are 
differently associated with the risk of incident AF.  
 
 
CHAPTER 4. METHODS 
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 METHODS 
4.1. STUDY POPULATION 
This thesis was based on the Danish cohort “Diet, Cancer and Health” 
which was established with the purpose of exploring the association 
between dietary habits in a middle-aged population and the future risk of 
developing cancer. To be eligible for the cohort, participants had to be 
born in Denmark and not registered with a diagnosis of cancer in the 
Danish Cancer Registry at the time of invitation. A total of 160,725 
Danish men and women aged 50-64 years, living in the urban areas of 
Copenhagen and Aarhus municipality received a written invitation 
between December 1993 and May 1997. If subjects had not responded 
within three weeks a first reminder was sent. If they did not reply to this 
within another three weeks a second reminder was sent. After this no 
further attempts were made to include the participant. A total of 57,053 
individuals (29,875 women and 27,178 men) accepted the invitation and 
provided written informed consent including permission for prospective 
data collection using their social security number and national registries. 
Information on participants’ dietary habits and lifestyle factors were 
obtained from questionnaires and interviews at a baseline visit to one of 
the study centres. At the baseline visit participants had anthropometric 
measurements done and biological material was sampled (49).  
A randomly drawn subcohort of 3,500 participants was used in studies 
with case-cohort designs e.g. when using adipose tissue samples (Study 2 
and 3 in this thesis). 
Participants with a delayed baseline registration of cancer in the Danish 
Cancer Registry were excluded from the cohort and in the studies 
included in this thesis, we excluded participants with a diagnosis of 
thyroid disease and known AF and/or AFL before baseline. Follow-up 
was until July 31st 2013, a diagnosis of AF/AFL in the Danish National 
Patient Register, death or emigration, whichever came first. 
The relevant ethics committees (project number: N-20160001) and the 
Danish Data Protection Agency (project number: 2015-186) approved the 
study. 
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4.2. FOOD-FREQUENCY QUESTIONNAIRES 
Prior to the baseline visit at a study centre the participants had 
completed a detailed, semiquantitative 192-item FFQ. The FFQ was 
developed for this cohort according to traditional Danish dietary habits. 
The FFQ was found to be a useful tool for categorizing individuals 
according to their intake of energy and nutrients when validated against 
a 7-day weighed dietary record (50). 
Participants were asked to report their average intake of different foods 
and beverages within the last 12 months in categories ranging from 
never up to ≥8 times a day. Intake of fatty acids such as SFA in g/day 
was calculated using the software FoodCalc (Center for Applied 
Computer Science, University of Copenhagen, DK; 
http://www.ibt.ku.dk/jesper/foodCalc) using standardized recipes and 
portion sizes for Danish dishes. In order not to overestimate the intake of 
specific dietary items, the questions on frequency of specific items were 
supplemented by questions regarding the intake of food groups such as 
vegetables – cooked or raw, meat and total fruits. Afterwards, the intake 
of the specific items was weighted according to the answers on intake of 
food groups (49–51) ensuring that there was concordance between e.g. 
number of carrots eaten and vegetables as a food group. 
4.3. ADIPOSE TISSUE 
All participants in the cohort had an adipose tissue biopsy taken at 
baseline.  
The adipose tissue biopsy was taken from the buttocks according to the 
method described by Beynen and Katan (52). In brief, the participant lied 
face down on an examination couch and the skin on the upper half of the 
buttocks was disinfected. The participants were instructed to tense 
his/hers muscles and a skinfold from the upper outer quadrant was held 
with one hand. This location was chosen to minimize the risk of 
damaging the ischiatic nerve (52). A luer lock system (Terumo, Terumo 
Corp, Tokyo, Japan) with a needle, a venoject multisample luer adaptor 
and an evacuated blood tube was inserted in an angle of about 45˚ with 
the other hand. After the procedure, the samples were flushed with 
nitrogen and stored at -150°C until analysis. Prior to analysis, the 
biopsies were thawed and a small amount of adipose tissue was removed 
and prewarmed at 50°C for 10 min. Still at 50°C, heptane was used to 
dissolve the fat and the fatty acids were transesterified for 2 min with 2 
mol/L KOH, according to the International Union of Pure and Applied 
Chemistry Standard Methods for the Analysis of Oils, Fats, and 
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Derivatives. The fatty acid composition was determined by gas 
chromatography using a Varian 3900 GC with a CP-8400 autosampler 
(Varian, Middleburg, The Netherlands) equipped with a flame ionization 
detector. Constant flow, split injection mode and a CP-sil 88 60m x 0.25-
mm internal diameter capillary column and temperature programming 
from 90°C to 210°C were used. Helium was used as the carrier gas. 
Commercially available standards (Nu-Chek-Prep, Inc, Elysian, MN, US) 
were used to identify the individual fatty acids (45,53). Results for each 
fatty acid were given as percentages of total fatty acids.  
4.4. OUTCOME 
The outcome in the studies was incident AF and/or AFL during the 
follow-up period for participants in the “Diet, Cancer and Health” cohort. 
Follow-up was from baseline until a diagnosis of AF/AFL in the Danish 
National Patient Register, death, emigration, or July 31st 2013, 
whichever came first. For study participants their social security number 
was linked to the Danish National Patient Register where information on 
AF status was retrieved. Since 1977 hospital discharge diagnoses have 
been recorded in the Danish National Patient Register and from 1995 
diagnoses from out-patient and emergency rooms visits have been 
recorded as well. Information regarding incident cases of AF and/or AFL 
was obtained using the 8th International Classification of Diseases (ICD-
8, code 427.4 in the international version and 427.93/427.94 in the 
Danish version) until the end of 1993. Afterwards, the 10th Revision of 
the International Statistical Classification of Diseases and Related 
Health Problems (ICD-10) (code I.48.9x) was used. A previous validation 
study (54) found a positive predictive value of the combined diagnosis of 
AF/AFL in this cohort to be 92.6% (95% CI 88.8% to 95.2%).  
4.5. STATISTICS 
We used time-to-event analysis with the combined diagnosis of AF and 
AFL being the event of interest. We employed Cox proportional hazard 
regression analysis with age as the underlying time axis and delayed 
entry to adjust optimally for age. Patients were considered at risk from 
baseline until the end of follow-up on July 31st 2013, a diagnosis of 
AF/AFL in the Danish National Patient Register, death or emigration, 
whichever came first. Due to age being the underlying time axis we 
adjusted all models for baseline age to ensure that the age of exposure 
data were comparable.  
Study 1 was a cohort design and the whole cohort was used in Cox 
proportional hazards regression analysis. We used substitution models 
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where total fat intake, total energy intake, and energy from protein and 
carbohydrates were kept constant (55). The regressions were set up in 
such a way that we compared the rate of AF between subjects having 
statistically replaced SFA with either MUFA or PUFA. 
Study 2 and 3 were based on fatty acid composition of adipose tissue and 
we therefore used a case-cohort design and weighted Cox proportional 
hazards regression. Adipose tissue composition was available for cases 
and all members of the subcohort. Weights were assigned to all 
participants according to the method described by Kalbfleisch and 
Lawless (56). The weight was one for all cases and biopsies from 
noncases in the randomly drawn subcohort were weighed as (number of 
noncases in the cohort)/(number of noncases in the subcohort). 
In Study 3, we examined patterns of fatty acids in adipose tissue using 
the statistical method treelet transform (TT) (57). TT is a data-driven 
dimension-reducing method that produce a number of factors, which 
account for much of the variation in the dataset. TT forms sparse 
patterns/factors of adipose tissue fatty acids where not all fatty acids 
contribute to every factor in contrast to the more widely used principal 
component analysis (58), thus, TT is considered simpler to interpret. 
When creating factors, multidimensional data becomes weighted 
averages for each individual. 
The output of TT is a dendrogram/cluster tree. The branches of the tree 
contains the related groups of variables. To extract factors/patterns the 
tree has to be cut. The optimal level at which to cut was determined by 
cross-validation with a range of factors as described by Gorst-Rasmussen 
(59). Scores for each case and participants in the subcohort were 
generated from the factors according to the individual’s fatty acid profile. 
Afterwards, quintiles for factors were used as exposure variables in 
weighted Cox proportional hazards regression. 
Analyses were stratified by sex in all three studies. Model assumptions 
for Cox proportional hazards regression were assessed with plots of 
Schoenfeld residuals versus age and were not violated (data not shown). 
A two-tailed p-value <0.05 was considered statistically significant. The 
latest available version of Stata statistical software (versions 14 and 15; 
StataCorp LP, College Station, TX, US) was used. 
  
CHAPTER 4. METHODS 
29 
Models 
As mentioned in “Chapter 2. Background” there are several known risk 
factors for AF. From the existing literature we a priori chose potential 
confounders and risk factors to adjust for in the analyses. The same three 
models apply for all three studies.  
Model 1: Minimally adjusted 
Categorical variable: 
 Baseline age in quintiles 
 
This was done to ensure that the age of exposure data were comparable 
when age was used as the time axis. This can be exemplified by 
considering two persons of the same sex who entered the study on the 
same date at 50 and 55 years of age, respectively. To compare their 
hazard of AF at 56 years of age, exposure data would be 6 years for the 
first participant and 1 year for the second participant. Thus, we adjusted 
for baseline age. 
Model 1A: Adjusted for Model 1 and for lifestyle factors. 
Categorical variables: 
 Years in school (≤7 years, 8 to 10, ≥10 years) 
 Smoking (never, former, <15, 15 to 25, >25 g/day)  
Continuous variables were adjusted for as restricted cubic splines with 
five knots positioned as described by Harrell (60). 
 Body mass index (kg/m2) 
 Waist circumference (cm)  
 Alcohol intake (g/day) 
 
By adjusting for lifestyle factors the risk of potential confounding was 
reduced. 
Model 2: Adjusted for Model 1A and for comorbidities registered at 
baseline. Disease data were retrieved from national registries. 
Categorical variables: 
 History of hypertension and/or treatment for hypertension (yes/no) 
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 History of hypercholesterolemia and/or cholesterol-lowering 
treatment (yes/no) 
 Angina pectoris (yes/no) 
 Heart failure (yes/no) 
 Previous myocardial infarction (yes/no) 
 Diabetes mellitus (yes/no) 
 Renal disease (yes/no) 
 
The comorbidities are strong risk factors for developing AF, hence they 
should be included in the model in order to avoid bias. Adjusting for 
these comorbidities could, however, cause bias by being potential 
intermediate variables. Hereby risk factors for the comorbidities become 
confounders. For the comorbidities included in this study this might be a 
minor problem, as most of the risk factors for developing the listed 
comorbidities are common to those of AF
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 STUDIES 
A flowchart of the participants in the “Diet, Cancer and Health” cohort 
and the three studies are shown in Figure 3.  
 
Figure 3. Flowchart of the cohort and overview of the three 
studies.  
Note: More adipose tissue samples are missing in Study 3 than Study 2 
because Study 2 only included the major SFA while Study 3 also involved 
fatty acids found in smaller concentrations in adipose tissue. 
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5.1. STUDY 1 
Aim 
In Study 1, we wanted to explore how substituting dietary SFA (C12:0-
24:0) with MUFA or PUFA affected the risk of developing AF in men and 
women. The a priori hypothesis was that replacing SFA with MUFA or 
PUFA would lower the risk of AF. 
Study design 
A cohort study where participants in the “Diet, Cancer and Health” study 
were followed using data on AF status from the Danish National Patient 
Register.  
Methods 
Data on dietary intake of fatty acids originated from the 192-item FFQ 
answered by all participants at baseline. If data on covariates were 
missing participants were excluded. The intake of fatty acids in g/day 
was calculated using standardized recipes and portion sizes for Danish 
dishes. 
Data were analysed by Cox proportional hazards regression with age as 
the time axis. All models were adjusted for age at baseline in quintiles to 
ensure that the age of exposure data were comparable. Substitution 
models kept total fat intake, total energy intake, and energy from protein 
and carbohydrates constant (55). Then, we statistically substituted 1 
g/day of SFA with 1 g/day of MUFA, PUFA, total n-3 PUFA, total n-6 
PUFA, and the major dietary n-6 PUFA linoleic acid. 
Main results from the study 
A total of 5,080 cases of AF occurred during a median follow-up of 17 
years. AF occurred more often in men than in women (3,119 cases/7.8 per 
1000 person-years vs. 1,961 cases/4.2 per 1000 person-years, 
respectively). 
Men had a HR of 1.08 (95% CI 1.02 to 1.14) when replacing 1 g/day of 
SFA with 1 g/day of total n-3 PUFA, while no statistically significant 
association was found when substituting SFA with MUFA, total PUFA or 
n-6 PUFA. In women, no statistically significant associations when 
substituting SFA with PUFA or MUFA could be demonstrated. 
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Strengths and limitations 
The study had several strengths: If a person were to lower the intake of 
SFA without losing weight then dietary SFA would have to be replaced 
by something else e.g. the use of vegetable oils instead of butter when 
preparing food. Thus, substitution models simulates the way we eat and 
ensures a clear interpretation of the results. We used national registries 
on vital and disease status, which provided a long and almost complete 
follow-up. We used a validated FFQ (50,51) and the positive predictive 
value for the diagnosis of AF was high in the cohort (54). Furthermore, 
due to the large number of cases we were able to investigate the 
association for men and women separately.  
The study also had limitations: Study participants were all Caucasians 
and middle-aged at inclusion, thus the results may not be valid in other 
race or age groups. Unfortunately, we only had information on diet at 
baseline and a change in the participant’s diet during the follow-up 
period could potentially affect the risk of developing AF. Due to the 
participants being middle-aged they might, however, have a more stable 
diet than e.g. younger individuals. We adjusted for known confounders 
for AF registered at baseline which did not alter the results but there is 
always the possibility of residual confounding e.g. from hereditary factors 
which we did not have any information on. We were only able to identify 
cases of AF diagnosed in hospitals and some patients might have been 
treated by a private practising cardiologist or general practitioners. Also, 
patients with minor symptoms might not have sought medical help. 
Finally, as this was an observational study we were not able to establish 
causality, only suggest associations. 
Main conclusions from the study 
In contrast to the a priori hypothesis, we found that men had a higher 
hazard of AF when replacing dietary SFA with total n-3 PUFA. In 
women and when substituting SFA with MUFA, total PUFA, or n-6 
PUFA we could not demonstrate a lower hazard of AF as hypothesized. 
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5.2. STUDY 2 
Aim 
The aim of the study was to investigate the association between adipose 
tissue content of total SFA including the major SFA C14:0, C16:0 and 
C18:0 and the risk of developing AF. Our hypothesis was that a high 
adipose tissue content of SFA was associated with development of AF. 
Study design 
The study was a case-cohort study based on the “Diet, Cancer and 
Health” cohort.  
Methods 
Adipose tissue composition was available for all cases and participants in 
the randomly drawn subcohort and was analysed as described in section 
“4.3. Adipose Tissue”. Information on AF status was found in national 
registries. We calculated hazard ratios (HR) for the exposure in quintiles 
using weighted Cox proportional hazards regression with age as the time 
axis and the first quintile as the reference. To examine SFA as a 
continuous variable we used restricted cubic splines with three knots in 
order to see a potential non-linear association (60). 
Radar plots provided the possibility of visually exploring underlying 
dietary patterns associated with higher levels of SFA in adipose tissue 
(61).  
We calculated the Pearson correlation coefficients for adipose tissue 
content of SFA and the dietary intake of SFA adjusted for total energy 
intake in men and women separately. 
Main results from the study 
A total of 4,722 cases of AF occurred during a median follow-up of 14.6 
years. 
A statistically significant association between adipose tissue content of 
SFA in quintiles and the rate of AF could not be established in either 
men or women in any of the three models. 
When examining dose-response relationship we found a slightly inverse 
U-shaped curve in men and a slightly U-shaped curve in women in all 
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three models. None of these associations were, however, statistically 
significant.  
The radar plots illustrated that a diet rich in SFA was associated with 
higher levels of SFA in adipose tissue, while a low content of SFA in 
adipose tissue was associated with a diet usually considered healthier in 
both men and women.  
The Pearson correlations coefficients adjusted for total energy intake 
relating dietary intake of SFA to their content in adipose tissue were low 
(r = 0.17 for men and r = 0.14 for women). 
Strengths and limitations 
The study had some strengths: We had a large number of cases which 
made it possible to investigate the association for men and women 
separately. The use of national registries provided us with long and 
almost complete follow-up and the diagnosis of AF in this cohort has been 
validated previously (54). We used adipose tissue, which is rarely 
available in other large cohort studies, as an objective marker of the 
body’s exposure to SFA. 
However, there were some limitations: The adipose tissue content of 
other SFA such as C12:0, C20:0 and C22:0 was too low to meaningfully 
examine their potential association with AF. The content of SFA was 
reported as percentages of total fatty acids, thus depending on the 
content of other fatty acids, which may be considered a limitation. The 
adipose tissue biopsy was only taken at baseline so adipose tissue 
composition might have changed if the participants had altered lifestyle 
and dietary habits during the follow-up period. Furthermore, we used 
subcutaneous adipose tissue from the buttocks, which may contain more 
MUFA and less SFA than subcutaneous abdominal adipose tissue (62–
64). Also, the low correlation coefficients relating dietary SFA intake to 
SFA content in adipose tissue suggest that adipose tissue content of AF 
is not a good objective marker of the long-term dietary intake of SFA. All 
participants were Caucasians and middle-aged at enrolment so the 
results may not apply for other race or age groups. 
Main conclusions from the study 
In this study we did not confirm the hypothesis of a direct association 
between adipose tissue content of SFA and the risk of AF. In contrast, 
our findings suggest a neutral association between adipose tissue content 
of SFA and the risk of developing AF.  
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5.3. STUDY 3 
Aim 
To explore the association between fatty acid patterns in adipose tissue 
and the risk of incident AF. Our hypothesis was that certain patterns of 
fatty acids would be associated with AF. Especially, if a pattern 
containing SFA was identified by TT, this would be associated with an 
increased risk of incident AF. 
Study design 
The study was a case-cohort study.  
Methods 
Adipose tissue composition was available for all cases and the randomly 
drawn subcohort and was analysed as described in section “4.3. Adipose 
Tissue”. Information on AF status was obtained from national registries. 
We performed TT as described in section “4.5. Statistics”. Quintiles of 
factors were used as the exposure variables in weighted Cox proportional 
hazards regression with the first quintile as the reference.  
Main results from the study 
During a median follow-up of 14.6 years, 4,710 participants developed 
AF.  
We identified seven factors from the dendrogram containing eight fatty 
acids at the most and they explained 66% of the fatty acid variance in 
the subcohort. 
TT1 contained SFA, while TT2 consisted of trans fatty acids and TT3 
consisted of marine n-3 PUFA. TT4 contained n-6 PUFA (except linoleic 
acid), TT5 contained n-9 fatty acids, while TT6 consisted of minor 
products of stearoyl-CoA desaturase and TT7 consisted of the plant-
based n-3 PUFA α-linolenic acid and the n-6 PUFA linoleic acid. 
For men in TT1, there were a neutral to weakly negative association for 
AF with HR = 0.82 (95% CI 0.65 to 1.02) in the fifth quintile compared to 
the first quintile, while for women the HR was 0.76 (95% CI 0.58 to 0.99), 
suggesting a potentially lower hazard of AF associated with a pattern 
with SFA. 
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Patterns with marine n-3 PUFA (TT3) and n-9 fatty acids (TT5) were 
associated with a lower hazard of AF in women, but not in men. Patterns 
with n-6 PUFA (TT4) was associated with a lower hazard of AF in both 
women and men.  
Strengths and limitations 
This study had several strengths: We studied the naturally occurring 
adipose tissue fatty acid patterns and their association with the hazard 
of developing AF. We did so in a large cohort with a long and almost 
complete follow-up for both AF and vital status. The diagnoses of AF in 
this cohort had previously been validated with a high positive predictive 
value (54). If AF cases were misclassified this would unlikely be 
associated with the exposure and would therefore lead to an 
underestimation of a potential association.   
The study also had limitations: Adipose tissue samples were obtained 
once, so a change in the participants’ dietary habits, lifestyle and 
metabolism could change the composition of fatty acids in adipose tissue 
and thereby the patterns found by TT, which this study would be unable 
to capture. All study participants were Caucasians and 50-64 years old at 
enrolment so the results may not be valid in other race or age groups. 
Also, there is always a possibility of residual confounding. 
Main conclusions from the study 
We found that a pattern with SFA may be associated with a lower hazard 
of AF in women. A priori we had expected that patterns with SFA would 
be associated with a higher hazard of AF. In both men and women 
patterns with n-6 PUFA may be associated with a lower hazard of AF 
and finally, patterns with marine n-3 PUFA and n-9 fatty acids were 
associated with a lower hazard of AF in women. 
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 DISCUSSION 
The aim of this thesis was to explore the association between 
substitution of dietary fatty acids and adipose tissue content of SFA and 
development of AF as well as the association between adipose tissue 
patterns of fatty acids and the risk of incident AF. The a priori 
hypothesis was that SFA would be associated with a higher risk of 
developing AF. The studies were based on the large Danish cohort “Diet, 
Cancer and Health” that included more than 57,000 participants with 
information on dietary intake of SFA and adipose tissue biopsies 
available for fatty acid composition analysis as a biomarker of SFA 
exposure.   
In Study 1, we examined how replacement of dietary SFA with either 
MUFA or PUFA was associated with the risk of AF in men and women. 
In study 2, we explored the association between adipose tissue content of 
the major SFA and the risk of incident AF. Adipose tissue content of fatty 
acids is considered an objective long-term marker of both the dietary 
intake and metabolism within the previous 1-3 years and of the de novo 
lipogenesis within the body (62,64–66). In Study 3, we identified patterns 
of fatty acids in adipose tissue by TT and estimated the risk of AF 
associated with each pattern. 
The mainly neutral findings for the association between SFA and 
incident AF presented in this thesis and associated papers (45,67) cannot 
be directly compared to the existing literature due to different analytical 
materials and methods. Table 2 provides a summary of the three studies 
presented in this thesis compared to the papers by Fretts et al. (18) and 
Chiuve et al. (17). 
SATURATED FATTY ACIDS AND THE RISK OF ATRIAL FIBRILLATION 
 
 
40
 
 
 
CHAPTER 6. DISCUSSION 
41 
In contrast to our hypothesis, the main finding of Study 1 (67) was a 
moderately higher risk of AF with a HR of 1.08 (95% CI 1.02 to 1.14) 
when 1 g/day of dietary SFA was replaced by n-3 PUFA in men. For 
women there were no association between replacing SFA with n-3 PUFA 
and incident AF (HR 0.99, 95% CI 0.90 to 1.08). It is unknown why an 
association was only seen in men but it might be due to differences in sex 
hormones, which may affect metabolic processes involved in the 
processing of fatty acids. It would have been of interest to separate the 
marine n-3 PUFA and the plant-based n-3 PUFA α-linolenic acid, but 
this was unfortunately not possible since the median consumption of 
total n-3 PUFA was 2.4 g/day of which the intake of marine n-3 PUFA 
was only 0.6 g/day. Several studies examining the effect of dietary 
marine n-3 PUFA and the risk of AF has been published previously. In 
this cohort, Rix et al. (11) reported a U-shaped association between the 
intake of marine n-3 PUFA and the risk of incident AF and found that 
the lowest risk of AF was close to the median intake of marine n-3 PUFA 
(0.6 g/day) in the population with higher risks observed with both very 
low and high intakes of marine n-3 PUFA. In another large study, 
Mozaffarian et al. (13) investigated the association between fish intake 
and the risk of AF in a population-based cohort of 4,815 adults including 
980 cases of AF and found that fish intake ≥1 time a week was associated 
with a significantly lower risk of AF. Studies on dietary intake of α-
linolenic acid and the risk of AF have not demonstrated any associations 
(68).  
A study by Chiuve et al. (17) (Table 2) found that replacing 5% of dietary 
energy from carbohydrates with SFA was associated with a higher risk of 
persistent and chronic AF in women (33,665 women including 1441 cases 
of AF) with a HR of 1.47 (95% CI 1.04 to 2.09). If MUFA replaced energy 
from carbohydrates a lower risk of persistent and chronic AF with a HR 
of 0.67 (95% CI 0.46 to 0.98) was found. The results can, however, not be 
directly compared to ours since we substituted SFA with unsaturated 
fatty acids and not with carbohydrates. When we substituted SFA with 
MUFA we found a neutral association with AF for both men and women 
in all three models. This was somewhat unexpected since the large 
Prevención con Dieta Mediterránea (PREDIMED) trial previously 
reported that supplementing a Mediterranean diet with extra-virgin 
olive oil significantly reduced the risk of incident AF (69). An explanation 
for this could be that a traditional Danish diet does not resemble the 
Mediterranean diet and that the MUFA Danes consume may not come 
from pure vegetable oils but from other sources such as mayonnaises and 
other dressings, which in turn may be associated with a diet considered 
unhealthy. 
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Chiuve et al. (17) also investigated the association between quintiles of 
SFA intake in energy percentages and the risk of incident AF using the 
first quintile as the reference. This model does not incorporate 
substitution and can therefore not be directly compared to Study 1. The 
authors did not find an association between dietary intake of SFA in 
quintiles and the risk of paroxysmal AF where none of the individual HR 
were statistically significant and the p-value for trend was >0.05. When 
looking at the HR for persistent/chronic AF there was a statistically 
significant higher hazard of AF in the fifth quintile compared to the first 
quintile and a significant trend for a higher risk of AF (p ≤0.03), 
suggesting a higher risk of developing more sustained forms of AF with a 
higher intake of C4:0 to C10:0, C12:0 and C14:0 as well as of C16:0. 
Intake of C18:0 was on the other hand not associated with any forms of 
AF development. 
The main findings of Study 2 (45), where we examined adipose tissue 
composition of fatty acids, did not confirm our a priori hypothesis of an 
association between adipose tissue content of SFA and a higher risk of 
incident AF. In contrast, we found neutral associations both when 
investigating the SFA content in quintiles and as a continuous variable 
for both men and women. The study included adipose tissue content of 
the major SFA C14:0, C16:0 and C18:0. We chose not to investigate the 
association between adipose tissue content of individual SFA and the 
risk of AF since dietary SFA originates from shared food sources (Table 
1) (44).  
We calculated Pearson correlation coefficients (adjusted for total energy 
intake) between dietary intake of the major SFA and their adipose tissue 
content of these. For men we found r = 0.17 and for women r = 0.14. 
Thus, the adipose tissue content of SFA was not a good objective measure 
of the dietary intake of SFA in this cohort. In a validation study prior to 
establishment of the “Diet, Cancer and Health” cohort the Pearson 
correlation coefficient for adipose tissue content of SFA and another FFQ 
than used in this study was 0.27 in men and 0.23 in women (70). These 
and our findings were in line with previous studies. Thus, Baylin and 
Campos (71) also reported low correlation coefficients for SFA in the diet 
and in adipose tissue and argued that this was probably due to de novo 
lipogenesis, which is in line with the interpretation by other authors (18). 
Thus, German and Dillard (44) proposed that dietary intake of fatty 
acids determines less than 25% of the interpersonal variance in adipose 
tissue composition. In contrast, adipose tissue may serve as a more 
accurate biomarker for odd numbered SFA, such as C15:0 and C17:0 that 
cannot by endogenously synthesized (71). It has been suggested that de 
novo lipogenesis of SFA is sparse when consuming sufficient energy and 
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>25% of energy is from fat (64), which was the case in this cohort where 
the median energy intake from fat was >30% in both sexes. Although not 
a good objective measure of the dietary intake of SFA in this cohort, 
adipose tissue is a measure of the body’s endogenous exposure to SFA 
and is determined by dietary intake of fatty acids as well as de novo 
lipogenesis from ingested carbohydrates and proteins (38–42). 
The association between content of SFA in adipose tissue and dietary 
SFA is illustrated by radar plots (61) in Figure 4. 
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Men
  
Women 
   
Figure 4. Radar plots. The median intake of selected food groups for 
participants in the lowest and highest quintiles of adipose tissue content 
of total SFA. The median in each group was indexed according to the 
overall median (grey line). Median intake in the lowest quintile (green 
line) and the highest quintile (blue line). Reproduced with permission 
from Dinesen PT, Rix TA, Joensen AM, Tjønneland A, Lundbye-
Christensen S, Overvad K, et al. Adipose Tissue Content of Saturated 
Fatty Acids and Atrial Fibrillation: a Case-cohort Study. Eur J Clin 
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Clinical Investigation Journal Foundation.  
Radar plots (Figure 4) evaluates the association between dietary patterns 
illustrated by median intake of food groups and adipose tissue content of 
SFA in percent. Patterns illustrate differences in the underlying dietary 
patterns for participants with high and low adipose tissue content of SFA 
and the interpretation is based on knowledge of dietary sources of SFA. 
In both men and women there appeared to be an association between a 
diet rich in SFA and the content of SFA in adipose tissue. Furthermore, 
for women there appeared to be an association between consumption of 
alcohol and adipose tissue content of SFA. Alcoholic beverages is not a 
major source of SFA but dietary patterns rich in SFA can be associated 
with a higher consumption of alcohol. 
Fretts et al. (18) (Table 2) used plasma phospholipids instead of adipose 
tissue as a biomarker of the body’s exposure to SFA. Their results 
showed that higher circulating plasma levels of C16:0 were associated 
with a higher risk of AF when comparing the highest with the lowest 
quartile. Higher circulating levels of C18:0 to C24:0 were associated with 
a lower risk of incident AF when comparing the highest with the lowest 
quartile. When investigating C16:0 to C24:0 the association with incident 
AF was neutral. This suggests that chain length may be of importance 
for the effect of SFA on incident AF. The results, however, cannot be 
directly compared to ours as plasma phospholipids is a more short-term 
biomarker than adipose tissue used in our study (62,64,72). 
Regarding circulating levels of SFA, we investigated the association 
between baseline serum content of SFA (C16:0 and C18:0) and the 
prevalence of AF in the Norwegian Omega-3 fatty acids in Elderly 
patients with Myocardial Infarction cohort (73) in an unpublished 
conference abstract. These analyses consisted of 534 individuals aged ≥70 
years of which 67 had a diagnosis of AF at baseline. We found that there 
might be a protective association between serum content of SFA and the 
prevalence of AF with an odds ratio of 0.64 (95% CI 0.31 to 1.30) for the 
fourth quartile compared with the first quartile but confidence intervals 
were wide, possibly due to the relatively low number of cases. 
Exploring patterns of fatty acids in adipose tissue (as done in Study 3), 
may provide new important information on how fatty acid patterns is 
associated with the risk of incident AF because individual fatty acids are 
highly correlated as a result of shared dietary sources and metabolic 
pathways (74). By using the statistical method TT, patterns were formed 
based on correlations between variables. A fatty acid is only contained in 
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one pattern and therefore TT is considered easier to interpret than the 
more widely used principal component analysis (58). Fatty acid patterns 
identified in Study 3 were characterized by the chemical structure of the 
fatty acids, which was also the case in a previous study using principal 
component analysis (75). 
A priori, it was expected that a pattern containing SFA would be 
positively associated with AF. The analyses did not confirm this 
hypothesis in men, where we found a neutral to weak negative 
association with AF, with a HR of 0.82 (95% CI 0.65 to 1.02) between the 
highest quintile and the lowest quintile. In women, a pattern with SFA 
was associated with a statistically significant lower hazard of AF in 
quintile 5 compared to the first quintile with a HR of 0.76 (95% CI 0.58 to 
0.99). As previously mentioned, the association between SFA and the risk 
of developing AF has shown conflicting results (17,18,45,67,76).  
An inverse association between a marine n-3 PUFA pattern and AF was 
only seen in women. Similarly, previous studies on adipose tissue marine 
n-3 PUFA and the risk of AF have shown inconsistent results. A previous 
study on the subcohort used in Study 3 of this thesis, showed that marine 
n-3 PUFA in adipose tissue had a monotonic, negative dose-response 
trend suggestive of a negative association between marine n-3 PUFA and 
development of AF, although the association did not reach statistical 
significance (77). Another biomarker of seafood consumption is 
circulating marine n-3 PUFA, and its association with AF has previously 
shown conflicting results. Thus, Gronroos et al. (12) did not find an 
association between plasma levels of eicosapentaenoic acid and 
docosahexaenoic acid and incident AF, while Virtanen et al. (15) found 
that higher levels of marine n-3 PUFA in serum may protect against AF. 
A pattern consisting of the plant-based α-linolenic acid and the n-6 PUFA 
linoleic acid was neutrally associated with the hazard of AF in both 
sexes. Previous studies on dietary intake and circulating levels of α-
linolenic acid and the risk of AF have not established an association 
(15,68) and notably a combined intake of arachidonic and linoleic acid 
was not associated with AF in the large Framingham Heart Study (78). 
We did not identify published studies regarding the association between 
adipose tissue patterns of trans fatty acids, n-6 PUFA (except linoleic 
acid) or n-9 fatty acids, and the risk of incident AF. 
As seen in Table 2, the papers behind this thesis combines SFA as the 
exposure, while the other studies have explored individual SFA and the 
risk of incident AF. Due to the shared dietary sources (Table 1) and 
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metabolic pathways of SFA, individual SFA as exposure may introduce 
problems (44). As an example, C16:0 and C18:0 share dietary sources. 
Thus, when exploring e.g. C16:0 as an individual exposure there could be 
a positive association with AF, but due to C16:0 and C18:0 being highly 
correlated there is the risk of collinearity. Adjusting for C18:0 would not 
be an optimal solution, as the interpretation would be unclear and it 
would not be possible to solely consume C16:0 and not C18:0 due to the 
shared dietary sources. 
The studies by Fretts et al. (18) and Chiuve et al. (17) excluded 
participants with coronary heart disease and CVD at baseline, while we 
adjusted for previous myocardial infarction, and angina pectoris because 
myocardial infarction has been found to be positively associated with 
incident AF (28,79). As mentioned previously, adjustment for 
comorbidities may cause bias. Some participants will develop CVD 
during follow-up, which was adjusted for as a time-varying covariate by 
Chiuve et al. (17). We did not adjust the results using time-varying 
covariates because suffering from an acute myocardial infarction or other 
CVD during follow-up may alter the participants’ diet and therefore also 
the exposure. If exposure information was updated after the event, time-
varying covariates could have been a possibility as both information on 
exposure and covariates would then have been updated (80,81). However, 
this would change the research question. Chiuve et al. (17) administered 
a second FFQ and updated the exposure data, which attenuated the 
association between SFA and the risk of persistent/chronic AF, which 
was no longer statistically significant when substituting energy from 
carbohydrates with energy from SFA. 
We did not have information on plasma concentrations of SFA in this 
cohort, otherwise it would have been of interest to explore the association 
between plasma concentrations of SFA and the hazard of AF and 
compare the results to those reported by Fretts et al. (18). Finally, 
Chiuve et al. (17) found that the effect of SFA differed between 
paroxysmal and chronic AF. However, the analytical method used by 
Chiuve et al. (17) does not answer this question sufficiently as their 
analyses does not reflect the association between SFA and progression 
but solely which diagnoses the patient receive within two years of the 
initial diagnosis. In our cohort, the diagnoses of all AF types and AFL 
were combined as one outcome variable. If we wanted to investigate 
progression from paroxysmal AF to longer-lasting forms this would 
require registration of subtypes and the use of a so-called multistate 
model. 
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 CONCLUSIONS AND 
PERSPECTIVES 
This thesis examined the association between dietary intake and adipose 
tissue content of SFA, as well as how patterns of fatty acids in adipose 
tissue was associated with incident AF. 
We found that replacing dietary SFA with n-3 PUFA was associated with 
a higher the risk of AF in men, while the association was neutral in 
women. Substituting SFA with MUFA, total PUFA, n-6 PUFA or the 
major n-6 PUFA linoleic acid was not associated with the risk of incident 
AF. 
Next, we explored if adipose tissue content of SFA was associated with 
the development of AF. Results showed a neutral association between 
adipose tissue content of SFA and the risk of AF in both men and women.  
Lastly, we identified patterns of fatty acids in adipose tissue and 
explored their association with AF. A pattern with SFA was associated 
with a lower hazard of AF in women, while the association was neutral in 
men. Patterns with marine n-3 PUFA and n-9 fatty acids were both 
associated with a lower hazard of AF in women and a pattern with n-6 
PUFA (except linoleic acid) was associated with a lower hazard of AF in 
both men and women.  
AF remains a socio-economic burden to society and can have serious 
consequences for the affected individuals and their families, therefore 
preventive initiatives are essential. The mainly neutral findings 
regarding SFA and AF presented in this thesis expand the findings from 
previous studies, suggesting that SFA is not associated with incident AF. 
However, SFA may have other adverse effects on CVD that needs to be 
taken into consideration regarding the overall health of patients (82).  
The existing literature on SFA and AF has explored diverse aspects 
including dietary intake of SFA and substitution of fatty acids and 
carbohydrates with SFA, circulating levels of SFA, adipose tissue content 
of SFA and adipose tissue patterns with SFA and none of these large 
observational studies have suggested a major clinically important 
association between SFA and incident AF. Thus, the need for additional 
observational studies seems limited. 
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